Pascal Claudepierre
Overview
Explore the profile of Pascal Claudepierre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
1637
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pina Vegas L, van Lunteren M, Loeuille D, Morizot C, Newsum E, Ramiro S, et al.
Eur Radiol
. 2025 Mar;
PMID: 40050452
Objectives: To investigate the occurrence of spinal degenerative lesions (DL)s in axial spondyloarthritis (axSpA) inception cohort in radiographs and MRI over 10 years (10Y), to assess their changes over time...
2.
Nguyen Y, Baron G, Hamamouche N, Belkhir R, Miconnet S, Soubrier M, et al.
Rheumatology (Oxford)
. 2024 Nov;
PMID: 39576675
Objectives: To evaluate the effectiveness of short message service (SMS) and/or email reminders in improving influenza vaccination coverage rates among rheumatoid arthritis (RA) patients treated with anti-TNF therapies, and to...
3.
Renard D, Tuffet S, Dieude P, Claudepierre P, Gossec L, Fautrel B, et al.
Joint Bone Spine
. 2024 Sep;
92(1):105778.
PMID: 39303938
Objectives: To investigate dietary practices and beliefs of patients with rheumatic and musculoskeletal diseases (RMDs) and associated factors. Methods: In 2019-2020, a cross-sectional multicentre study enrolled patients with inflammatory arthritis...
4.
Pina Vegas L, Iggui S, Sbidian E, Claudepierre P
RMD Open
. 2024 Aug;
10(3).
PMID: 39117446
Objectives: To assess the potential impact of targeted therapies for psoriatic arthritis (PsA) on symptomatic treatments (non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, opioid analgesics), methotrexate and mood disorder treatments and on...
5.
Molto A, Serrand C, Alonso S, Berenbaum F, Claudepierre P, Combe B, et al.
RMD Open
. 2024 Jul;
10(3).
PMID: 39043614
Background: Inception cohorts aim to describe chronic diseases from diagnosis and over years of follow-up. Axial spondyloarthritis (axSpA) diagnosis might be challenging during the first years of the disease. Thus,...
6.
Wendling D, Breban M, Costantino F, Lequerre T, Felten R, Ruyssen-Witrand A, et al.
Joint Bone Spine
. 2024 May;
91(6):105741.
PMID: 38795763
The progress observed over the last 30 years in the field of axial spondyloarthritis (axSpA) has not made it possible to answer all the current questions. This manuscript represents the...
7.
Ruyssen-Witrand A, Caillet-Portillo D, Najm A, Fogel O, Baillet A, Claudepierre P, et al.
Joint Bone Spine
. 2024 Apr;
91(5):105733.
PMID: 38604594
Introduction: National and international scientific societies advocate for a regular, systematic, and standardized global evaluation of axial spondyloarthritis (axSpA) patients. However, there are no recommendations specifying the content of this...
8.
Gossec L, Kerschbaumer A, Ferreira R, Aletaha D, Baraliakos X, Bertheussen H, et al.
Ann Rheum Dis
. 2024 Mar;
83(6):706-719.
PMID: 38499325
Objective: New modes of action and more data on the efficacy and safety of existing drugs in psoriatic arthritis (PsA) required an update of the EULAR 2019 recommendations for the...
9.
Bastard L, Claudepierre P, Penso L, Sbidian E, Pina Vegas L
RMD Open
. 2024 Mar;
10(1).
PMID: 38485454
Objective: To assess the risk of serious infection associated with different targeted therapies for psoriatic arthritis (PsA) in real-world settings. Methods: This nationwide cohort study used the administrative healthcare database...
10.
Dougados M, Lardy-Cleaud A, Desfleurs E, Claudepierre P, Goupille P, Ryussen-Witrand A, et al.
RMD Open
. 2024 Mar;
10(1).
PMID: 38428974
Objective: To compare the 1-year retention rate of secukinumab in axial spondyloarthritis (axSpA) and its predisposing factors with regard to its time of initiation (eg, right after or remotely from...